Urological cancer, Malmö
291 – 300 of 503
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2014
-
Mark
Plasma alkylresorcinol metabolites as biomarkers for whole-grain intake and their association with prostate cancer: a Swedish nested case-control study.
(
- Contribution to journal › Article
-
Mark
The fungal metabolite galiellalactone interferes with the nuclear import of NF-κB and inhibits HIV-1 replication.
(
- Contribution to journal › Article
-
Mark
Interobserver variability in the pathological assessment of radical prostatectomy specimens: Findings of the Laparoscopic Prostatectomy Robot Open (LAPPRO) study.
(
- Contribution to journal › Article
-
Mark
Galiellalactone is a Direct Inhibitor of STAT3 in Prostate Cancer Cells.
(
- Contribution to journal › Article
-
Mark
Preclinical evaluation of (111)In-DTPA-INCA-X anti-Ku70/Ku80 monoclonal antibody in prostate cancer.
(
- Contribution to journal › Article
-
Mark
Enzalutamide in metastatic prostate cancer before chemotherapy
(
- Contribution to journal › Article
- 2013
-
Mark
The Mutational Landscape of Prostate Cancer
(
- Contribution to journal › Scientific review
-
Mark
Infective Complications After Prostate Biopsy: Outcome of the Global Prevalence Study of Infections in Urology (GPIU) 2010 and 2011, A Prospective Multinational Multicentre Prostate Biopsy Study
(
- Contribution to journal › Article
-
Mark
Preclinical imaging of prostate cancer using radiolabeled antibodies
(
- Thesis › Doctoral thesis (compilation)
-
Mark
Low rate of lymphedema after extended pelvic lymphadenectomy followed by pelvic irradiation of node-positive prostate cancer
(
- Contribution to journal › Article